During the past decade, Jinan General Hospital of PLA conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jinan General Hospital of PLA" #1 collaborator was "Jiangsu Suzhong Pharmaceutical Group Co., Ltd." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jinan General Hospital of PLA" are "Artery Injury" (1 trials), "Chronic Kidney Disease" (1 trials), "IgA Nephropathy" (1 trials) and "Metastasis" (1 trials). Many other conditions were trialed in "Jinan General Hospital of PLA" in a lesser frequency.

Most popular intervention types in "Jinan General Hospital of PLA" are "Drug" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abelmoschus manihot" (1 trials), "Abelmoschus manihot (AM)" (1 trials), "Conventional Percutaneous Vertebroplasty" (1 trials), "Endovascular treatment" (1 trials) and "Losartan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jinan General Hospital of PLA" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Jinan General Hospital of PLA". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jinan General Hospital of PLA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jinan General Hospital of PLA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".